Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

steven_ferdman-getty_images

Pfizer CEO cashes in shares for $5.6m following strong Phase 3 COVID-19 vaccine data

November 12, 2020 Sales and Marketing COVID-19, Pfizer, Vaccine, pharma

With the news that Pfizer and BioNTech’s COVID-19 vaccine candidate demonstrated 90% efficacy in a Phase 3 interim analysis, it …
News
nice_reception_2

NICE recommends venetoclax combo, a non-chemo option for untreated chronic lymphocytic leukaemia

November 10, 2020 Manufacturing and Production, Sales and Marketing AbbVie, NHS, NICE, UK, leukaemia, venetoclax

NICE has recommended venetoclax in combination with obinutuzumab under final draft guidance for the first-line treatment of untreated chronic lymphocytic …
News
stethoscope_and_background_doctor

Scottish Medicines Consortium greenlights Nubeqa for prostate cancer

November 10, 2020 Manufacturing and Production, Sales and Marketing

The Scottish Medicines Consortium has approved Nubeqa for the treatment of men with non-metastatic castration-resistant prostate cancer (nmCRPC) who are …
News
astrazeneca_sign_sky

Argentina secures 22 million COVID-19 vaccine doses from AstraZeneca and Oxford Uni

November 9, 2020 Manufacturing and Production, Sales and Marketing Argentina, AstraZeneca, COVID-19, Vaccine

AstraZeneca has committed to an agreement to deliver 22 million doses of its COVID-19 vaccine candidate, co-developed in partnership with …
News
shutter

AstraZeneca’s Brilinta combo reduces rate of disabling stroke or death in stroke patients, according to Phase 3 data

November 9, 2020 Research and Development, Sales and Marketing AstraZeneca, Brilinta, pharma

AstraZeneca has unveiled new Phase 3 data for Brilinta (ticagrelor) as a treatment for patients who have suffered an acute …
News
1200px-vaccine_image_1

Head of UK’s COVID-19 vaccine taskforce faces questions over biotech fund

November 9, 2020 Sales and Marketing COVID, COVID-19, vaccines

Kate Bingham, the head of the British Government’s vaccine taskforce, faces scrutiny after it was revealed her venture capital firm …
News
fda_white_oak_building_web_0

FDA approves Nightware app on Apple Watch to treat sleep disturbances

November 9, 2020 Sales and Marketing

The FDA has authorised the marketing of Nightware, a digital therapeutic application for the Apple Watch, in treating sleep disturbances.  …
News
hiv_on_macrophage

Viiv Healthcare’s cabotegravir effective in HIV prevention in women

November 9, 2020 Sales and Marketing AIDS, HIV

Viiv Healthcare’s cabotegravir is more effective in preventing HIV in women than the oral standard of care, according to an …
News

China approves Astellas’ Xtandi in non-metastatic castration-resistant prostate cancer

November 6, 2020 Medical Communications, Sales and Marketing Astellas, China, NMPA, Xtandi

China’s drug regulator, the National Medical Products Administration (NMPA), has given the green light to Astellas to market Xtandi (enzalutamide …
News

NICE shoots down Bristol-Myers Squibb immunotherapy Opdivo for post-surgery skin cancer

November 5, 2020 Sales and Marketing BMS, Cancer, NHS, NICE, opdivo

NICE has rejected the routine use of Bristol-Myers Squibb’s immunotherapy Opdivo (nivolumab) on the NHS in England and Wales for …
News
tt

How the US election could affect the pharmaceutical industry

November 4, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Donald Trump, Joe Biden, Trump, US, US election 2020, pharma

The US is one of the most lucrative markets for the pharmaceutical industry. This is a country where a lack of …
Feature
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

November 4, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, GSK, Sanofi, UK, US, remdesivir

As European nations fall one by one back into lockdown, hopes weigh heavily on a vaccine to pave a path …
News

J&J’s appeal shot down over $2.12m payment due to allegedly carcinogenic talc products

November 4, 2020 Research and Development, Sales and Marketing J&J, JJ, baby powder, ovarian cancer, talc

Johnson & Johnson has suffered a legal defeat in its ongoing dispute with consumers over damages relating to use of …
News
800px-pfizer_finland_hq_february_13_2009_2

Pfizer announces €300m investment in Irish manufacturing sites

November 2, 2020 Sales and Marketing

Pfizer is set to invest €300 million in its three Irish manufacturing sites in Ringaskiddy, Dublin and Kildare.  The investment …
News
madrid_-_johnson__johnson_1

Johnson & Johnson to begin testing COVID-19 vaccine on adolescent patients

November 2, 2020 Sales and Marketing

Johnson & Johnson plans to start testing its COVID-19 vaccine candidate in adolescents between the age of 12 and 18.  …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026